Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody-Positive Individuals

Area of Science:

• Immunology
• Endocrinology
• Diabetes Research

Background:

• Type 1 diabetes is an autoimmune disease characterized by the presence of islet autoantibodies.
• Most individuals with multiple islet autoantibodies progress to clinical type 1 diabetes.
• However, some individuals experience a loss of these autoantibodies, termed reversion.

Purpose of the Study:

• To determine the frequency of autoantibody reversion in individuals positive for multiple autoantibodies.
• To investigate the association between autoantibody reversion and the progression to clinical type 1 diabetes.

Main Methods:

• Analysis of data from 3,284 multiple-autoantibody-positive individuals in TrialNet's Pathway to Prevention Study.
• Utilized Cox regression analysis to determine the effect of reversion on clinical disease progression.

Main Results:

• Autoantibody reversion occurred in 4.1% (134 subjects) of the studied population.
• Reversion was associated with a reduced incidence of clinical type 1 diabetes.
• Factors associated with a higher frequency of reversion included older age, lower autoantibody titers, and fewer positive autoantibodies.

Conclusions:

• Autoantibody reversion is a rare event in multiple-autoantibody-positive individuals.
• When reversion occurs, it significantly reduces the risk of progressing to clinical type 1 diabetes.
• The findings suggest the existence of unknown mechanisms that promote immune remission in certain individuals.